Lung Nodule Growth Rate Calculator

Assess malignancy risk of lung nodules using the Brock University cancer prediction model

Critical Medical Disclaimer

This calculator is for educational purposes only and should NOT be used for clinical decision-making without professional medical interpretation.

  • Results are statistical probabilities, not definitive diagnoses
  • Individual cases may vary significantly from population-based predictions
  • Always require radiologist and oncologist evaluation for nodule management
  • This tool cannot replace comprehensive clinical assessment
  • Urgent medical evaluation is needed for any lung nodule findings

Patient Demographics

Medical History

Chronic lung disease causing shortness of breath

First-line relatives with lung cancer history

Nodule Characteristics

Sunburst or corona radiata sign

Nodule located in upper part of lung

Total number of nodules found

Maximum diameter of largest nodule

CT appearance and density characteristics

Malignancy Risk Assessment

Enter required information to calculate malignancy risk

Age, nodule count, and nodule size are required

Example Risk Assessments

Low Risk Case

Patient: 45-year-old female, no emphysema, no family history

Nodule: 8mm solid nodule, lower lobe, no spiculation

Expected risk: <5% - Routine surveillance appropriate

Moderate Risk Case

Patient: 65-year-old male, emphysema present, no family history

Nodule: 12mm partially solid, upper lobe, no spiculation

Expected risk: 5-15% - Active surveillance recommended

High Risk Case

Patient: 72-year-old male, emphysema, family history positive

Nodule: 18mm solid nodule, upper lobe, spiculated borders

Expected risk: >30% - Urgent tissue sampling needed

Key Risk Factors

Age

Risk increases significantly with age

Male Sex

Higher baseline malignancy risk

Spiculated Borders

Strong predictor of malignancy

Upper Lobe Location

Associated with higher cancer risk

Nodule Size

Larger nodules have higher risk

Management Guidelines

Low Risk (<5%)

Routine CT surveillance at 12 months

Moderate Risk (5-15%)

CT surveillance at 6-12 months or consider PET

High Risk (15-30%)

Consider biopsy, PET scan, or surgical consultation

Very High (>30%)

Tissue sampling or surgical evaluation strongly recommended

About This Model

Based on Brock University cancer prediction equation

Validated for both solitary and multiple nodules

Predicts 2-4 year cancer development risk

Requires professional medical interpretation

Understanding Lung Nodule Risk Assessment

Model Foundation

This calculator uses the Brock University cancer prediction model, validated on large patient populations with lung screening CT scans. The model incorporates patient demographics, medical history, and nodule characteristics to provide statistical malignancy probability.

Key Variables

Patient factors: Age, sex, emphysema, family history

Nodule morphology: Size, type, spiculation, location

Imaging features: Solid vs. ground-glass appearance

Clinical Application

Screening Programs

Helps prioritize follow-up in lung cancer screening programs and optimize resource allocation for high-risk nodules.

Clinical Decision Support

Provides objective risk stratification to guide management decisions between surveillance, further imaging, or tissue sampling.

Patient Counseling

Offers quantitative risk estimates for informed patient discussions about nodule management options and follow-up plans.

Lung Cancer Statistics

Early Detection Impact

1cm nodules detected early can have 5-year survival rates up to 90%

Screening Benefit

Only 16% of lung cancers are diagnosed at early stage without screening

Risk Factors

Smoking accounts for 80-90% of lung cancers in the United States